Masterclass

Masterclass Cell-Based Bone Regeneration

Date:
30 October 2015 12:00 hrs. - 18:00 hrs.
Location:
Location see remarks
Title:
Cell-Based Bone Regeneration
Host(s):

Dr. Jeroen van den Beucken, Dept. of Biomaterials, Radboudumc

30-10-2015 12:00:0030-10-2015 18:00:00Europe/AmsterdamCell-Based Bone Regeneration Location see remarksRimlsrimls@radboudumc.nl

Remarks / more information:

Location:               De Vereeniging (Nijmegen, the Netherlands
Registration:         € 50,- (including lunch/drinks/snacks)


Program:        
12.00-13.00:
Lunch

13.00-13.45                  
Prof. Richard Oreffo (University of Southampton, UK)
New strategies for bone repair - harnessing skeletal stem cells and environmental niches through to the clinic

14.00-14.45                  
Prof. Sabine Fuchs (Universitätsklinikum Schleswig-Holstein, DE)
Outgrowth endothelial cells  for bone vascularization strategies:  from cellular interactions to biomaterial applications

15.00-15.45                  
Prof. Ivan Martin (University Hospital of Basel, CH)
Evolution of bone tissue engineering strategies

16.00-16.45                  
Prof. Pierre Layrolle (University of Nantes, FR)
The REBORNE project - Regenerating bone defects using new biomedical engineering approaches

17.00-18.00                  
Informal closure and drinks


Oreffo , RichardRichard Oreffo holds the chair of Musculoskeletal Science and is co-founder of the Centre for Human Development, Stem Cells and Regeneration at Southampton. Richard graduated from Liverpool and Oxford and spent a highly formative research period in Texas USA before returning to the UK. He has held positions at AstraZeneca, and University of Oxford before being appointed to a lectureship in 1999 at the University of Southampton. Richard was Director of Enterprise and then Associate Dean International and Enterprise from 2008-2013. Richard is internationally recognised for his work on skeletal biology and the mechanisms involved in skeletal stem cell differentiation and bone regeneration. Richard manages a significant research grant portfolio (Lola, EPSRC, MRC, EU, Industry) and has published over 200 peer-reviewed papers. He serves/has served on a number of Research Council Committees, is on the editorial boards of six journals and is a Fellow of the Institute of Biology.

 
Fuchs , SabineSabine Fuchs is a biologist and received her PhD in Biomedical Technology at the Saarland University. For subsequent postdoctoral training, Sabine went to the Institute of Pathology (Johannes Gutenberg University, Mainz), were she focused on vascularization strategies by combining angiogenic and osteogenic cells. Thereafter, Sabine was a group leader within the same institute and obtained her habilitation in Molecular Medicine at the Johannes Gutenberg University. In October 2011, Sabine was appointed as professor in Experimental Trauma Surgery at the Christian-Albrechts Universität (Kiel, Germany). The research interest of Sabine include 'in vitro models of the alveolar-capillary barrier based on primary human cells' and 'tissue engineering and regenerative medicine' with emphasis on vascularization strategies and cellular interactions involved in bone repair.

 
IMartin , Ivanvan Martin obtained his PhD in Biomedical Engineering at the University of Genova and received postdoctoral training at Harvard/MIT. In 1999, Ivan established a Research Group at the University Hospital of Basel.  His team includes scientists from the biological, engineering and clinical fields, dedicated to develop solid scientific basis towards cartilage, bone and osteochondral tissue regeneration. Ivan was the first Chair of the European section of TERMIS and is currently member of several editorial/reviewing boards and of the 'Mesenchymal stem cell committee' of the International Society for  Cellular Therapy (ISCT). In this field, Ivan is author of more than 160 peer-reviewed papers on international journals, accounting for an H-index of 47. The developed science and technology have been translated into three clinical trials for cell-based cartilage and bone repair, and into the founding of a spin-out company for the commercialization of tissue culture bioreactors (Cellec Biotek AG).


Layrolle , PierrePierre Layrolle obtained his PhD in biomaterials in 1994 at the Polytechnic National Institute of Toulouse and his thesis was awarded the Leopold Escande prize. He completed postdoctoral training in Japan and later joined the tissue engineering company IsoTis (NL) prior to enter INSERM in Nantes. Pierre is currently the coordinator of the FP7 REBORNE project, aimed at regenerating bone defects using a combination of stem cells and biomaterials. This project gathers 24 partners (academic labs, hospitals, and companies) in 8 European countries. His team has conducted a vast amount of pre-clinical studies and 5 clinical trials are currently underway. His work is routinely highlighted in national and international media. Pierre is inventor of 14 patents and co-founder of the spin-off company Biomedical Tissues that produces innovative medical devices based on biomimetic microfibrous polymer matrices. Pierre has authored over 130 peer-reviewed publications (h-index 39) is a member of the Editorial board of several journals and regularly invited to present at international conferences.

For information or registration:    

Jeroen van den Beucken
Ph van Leijdenln 25
6525 EX Nijmegen (the Netherlands)
+31(0)645198460
jeroen.vandenbeucken@radboudumc.nl

 



<< back to all events